Table 1. Abbreviated clinical data and single-cell metadata for each patient tumor.

The last two columns reflect the number of cells obtained post QC and in parentheses the total number of cells estimated by Cell Ranger. Asterisks in the Tumor site column denote a metastatic event. Race column abbreviations: African American (AA), Caucasian (CAU), Asian (AS). Extended clinical data for each patient (de-identified) can be found in Table S1.

Patient	Cancer type	Tumor site	Histology	Stage	Age	Race	BMI	scATAC-seq cells	scRNA-seq cells
Patient 1	Endometrial	Endometrium	Endometrioid	IA	70	AA	39.89	6,348 (6,649)	5,279 (5,697)
Patient 2	Endometrial	Endometrium	Endometrioid	IA	70	CAU	30.50	7,248 (6,658)	7,277 (7,963)
Patient 3	Endometrial	Endometrium	Endometrioid	IA	70	CAU	38.55	4,165 (7,241)	4,974 (6,054)
Patient 4	Endometrial	Endometrium	Endometrioid	IA	49	CAU	55.29	7,597 (7,917)	7,413 (8,110)
Patient 5	Endometrial	Endometrium	Endometrioid	IA	62	CAU	49.44	6,797 (7,881)	7,291 (8,403)
Patient 6	Endometrial	Ovary***	Serous	IIIA	74	CAU	29.94	6,643 (2,351)	6,866 (8,009)
Patient 7	Ovarian	Ovary	Endometrioid	IA	76	CAU	34.80	5,924 (7,107)	6,454 (8,295)
Patient 8	Ovarian	Ovary	HGSOC	IIB	61	CAU	22.13	8,014 (7,898)	7,454 (8,181)
Patient 9	Ovarian	Ovary	HGSOC	IIIC	59	AS	22.37	9,670 (9,942)	6,192 (6,939)
Patient 10	Ovarian	Ovary	Carcinosarcoma	IVB	69	CAU	23.72	4,439 (8,977)	7,663 (8,984)
Patient 11	Gastric	Ovary***	GIST	IV	59	CAU	33.96	7,776 (11,066)	8,660 (10,094)